W e studied the rates of revision for 53 698 primary total hip replacements (THRs) in nine different groups of disease. Factors which have previously been shown to be associated with increased risk of revision, such as male gender, young age, or certain types of uncemented prosthesis, showed important differences between the diagnostic groups. Without adjustment for these factors we observed an increased risk of revision in patients with paediatric hip diseases and in a small heterogeneous 'other' group, compared with patients with primary osteoarthritis. Most differences were reduced or disappeared when an adjustment for the prognostic factors was made. After adjustment, an increased relative risk (RR) of revision compared with primary osteoarthritis was seen in hips with complications after fracture of the femoral neck (RR = 1.3, p = 0.0005), in hips with congenital dislocation (RR = 1.3, p = 0.03), and in the heterogenous 'other' group. The analyses were also undertaken in a more homogenous subgroup of 16 217 patients which had a Charnley prosthesis implanted with high-viscosity cement. The only difference in this group was an increased risk for revision in patients who had undergone THR for complications after fracture of the femoral neck (RR = 1.5, p = 0.0005).
It has been thought that prostheses in patients with certain hip diseases have a higher risk of revision than others [1] [2] [3] [4] [5] and that the type of failure may be specific. 1, 2, 6 This concept was based on results from small studies 2, 3, 5 or those in which the type of prosthesis had not been taken into account. 1, 4 In Norway, as in most other countries, uncemented prostheses are most commonly used in young patients (< 60 years). 7 Thus, in some series the common combination of known negative prognostic factors such as young age, male gender and the first and second generations of uncemented prostheses, has given inferior results. This may have led to the conclusion that the primary disease of the hip in young men was responsible for the higher rate of revision.
In an attempt to assess the influence of disease on the risk of revision, we studied different groups among all primary total hip replacements (THRs) reported to the Norwegian Arthroplasty Register between September 1987 and January 1999. To adjust for the influence of the type of prosthesis so that the importance of the disease itself could be studied we used a Cox multiple-regression model. We also analysed a subgroup of patients with Charnley prostheses introduced with high-viscosity cement.
Patients and Methods
Since September 1987, information on all primary THRs and revisions undertaken at 68 hospitals in Norway has been recorded in the Norwegian Arthroplasty Register. 7 The register receives reports from approximately 95% of the hip replacements undertaken in Norway. 8 After each operation, a standard form is completed by the surgeon and sent to the register. An English translation of the form has been previously reported. 9 Information concerning revisions, defined as the surgical removal or exchange of a part of, or the whole implant, is linked to the data for the primary operation using the unique identification number assigned to each person in Norway.
For primary THR carried out between September 1987 and February 1999, we compared the time until revision for each group of disease. Seventy-four different diagnoses were reported. The eight most common, as shown in Table  I , were primary osteoarthritis, rheumatoid arthritis, complications after fracture of the femoral neck, congenital dysplasia, congenital dysplasia with dislocation, epiphysiolysis and Perthes' disease (which were reported as one group on the standard form), and ankylosing spondylitis. The avascular necrosis group was heterogeneous and included cases which were idiopathic, steroid-or alcohol-induced, occurred after renal transplantation, or were due to non-steroidal anti-inflammatory drug therapy or to radiotherapy. The eight most common diagnostic groups constituted 52 395 hips, and the 'others' (66 diseases) 1303. Separate analyses were carried out to determine if some of the diseases in the 'other' group had an especially high risk of revision. There were 53 698 primary THRs, of which 24 709 were cemented with antibiotic-impregnated cement, 18 252 were cemented without antibiotic in the cement, 6978 were uncemented prostheses, 2561 were hybrid prostheses with uncemented acetabular components, and there 1198 were with other combinations or with some missing information. Based on previous work, [10] [11] [12] we defined inferior uncemented prostheses as those with smooth press-fit stems, threaded cups with a smooth surface, or porous-coated stems without circumferential coating; 2399 of the 6978 uncemented prostheses belonged to this group. The surgeon could report one or more causes of failure leading to revision. Possible causes were aseptic loosening of the cup, aseptic loosening of the stem, dislocation, infection, fracture of the femur, pain and other causes. When seen in combination with any other cause, infection was considered as the primary cause of revision. Statistical analysis. In this study, the endpoint for survival was defined as revision when a part of, or the whole implant was removed or exchanged. Patients who had died or emigrated were identified from files provided by the Central Bureau of Statistics in Oslo, Norway, and the survival time of prostheses in these patients was thus censored at the day of death or emigration.
Survival of the prosthesis at ten years was estimated for each disease by the Kaplan-Meier method. 13 The follow-up period was 0 to 11.5 years. The median follow-up was calculated by the reverse Kaplan-Meier method. 14 The Cox multiple-regression model 15 was applied to study differences among the disease groups and to adjust for potential confounding by age (< 55, 55 to 60, 60 to 70, > 70 years), gender and the use of uncemented prostheses, inferior uncemented prostheses, hybrid prostheses, antibioticimpregnated cement and systemic antibiotic. The basis for these adjustments arose from earlier studies from the register. 8, [10] [11] [12] [16] [17] [18] Estimates from Cox analyses with disease as the strata factor were used to construct adjusted survival curves at mean values of the risk factors. The Wald test was used to calculate p values.
We also investigated whether the percentage of inferior uncemented prostheses varied with the type of disease. To eliminate any influence of the type of prosthesis, analyses were also undertaken in a homogenous subgroup of 16 217 Charnley prostheses (DePuy, Leeds, UK) cemented with high-viscosity Palacos cement with and without gentamicin (Schering-Plough International Inc, Kenilworth, New Jersey) and Simplex with and without erythromycin/colistin (Howmedica International, London, UK).
Both in the overall total and in the Charnley subgroup, all analyses were undertaken separately for the age group less than or equal to 60 years and the age group above 60 years. This was to avoid confounding between youth and the use of an uncemented prosthesis. In the Charnley subgroup, we also compared time until revision among diseases in separate analyses in which endpoints were defined according to specific causes of revision.
For the statistical analyses we used the software SPSS (SPSS Inc, Chicago, Illinois) 19 and S-PLUS (Statistical Sciences Inc, Seattle, Washington).
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Results
Among patients who received Charnley prostheses (Charnley subgroup) 47 different diseases were registered. The eight most common diagnoses are given in Table I (overall total) and Table II (Charnley subgroup) . Patient characteristics, choice of prosthesis and cement in the different diagnostic groups. The two most common diseases reported were primary osteoarthritis and complications after fracture of the femoral neck. Only 9% to 10% of the patients with these diseases were aged less than 60 years at the time of the primary operation whereas in the other diagnostic groups the percentage ranged from 30% to 70% (Table I) . Several factors such as male gender, young age or having an uncemented prosthesis have been associated with increased risk of revision. Some specific uncemented designs have been particularly implicated. The distribution of these prognostic factors showed large variations between the different diagnostic groups (Tables I and II ). In the less common groups, such as congenital dysplasia and dislocation of the hip, complications after epiphysiolysis and Perthes' disease, ankylosing spondylitis and avascular necrosis, the use of inferior uncemented prostheses ranged from 11.6% to 21.0%, compared with 2.4% to 5.2% in the more common groups such as primary osteoarthritis, rheumatoid arthritis and complications after fracture of the femoral neck (Table I ). This reflected the tendency to use uncemented prostheses in groups of hip disease with a high percentage of young patients (Table I ). In patients aged 60 years or younger more than 50% of the prostheses were uncemented, in all disease groups. In the group with complications after epiphysiolysis and Perthes' disease 80% of the acetabular components were uncemented and 25% were inferior uncemented components (Table I ). The Cox regres-sion of the total data showed that, compared with using antibiotic-loaded cement, the risk was increased 1.8 times (1.7 to 2.0, p < 0.0001) for revision using a cement without antibiotic. Furthermore, it has increased 3.4 times (2.9 to 3.9, p < 0.0001) when using an inferior uncemented implant, and 1.4 times (1.2 to 1.6, p = 0.0002) with an uncemented implant not classified as inferior. We observed an increased risk of 1.5 times (1.2 to 1.9, p = 0.001) for revision using a hybrid prosthesis with an uncemented acetabulum and a cemented femur with antibiotic-loaded cement, and of 2.3 times (1.8 to 2.9, pp < 0.0001) with a hybrid uncemented acetabulum with a cemented femur without antibiotic in the cement. We observed an increased risk of revision in young patients, but this difference was not found in the subgroup of Charnley prostheses. Both in the overall total and the Charnley subgroup the risk of revision was almost doubled in men. Follow-up results for all primary operations. The survival results using all causes of revision as an endpoint are given in Table III and Figure 1 . In unadjusted survival analyses, we found statistically significant differences in the different disease groups (Table III) . THR in patients with paediatric diseases (congenital dysplasia or dislocation of the hip, epiphysiolysis and Perthes' disease) and the heterogenous 'other' group had worse results compared with patients with primary osteoarthritis (Table III) . Most differences disappeared after adjustment for age, gender, antibiotic-impregnated cement, systemic antibiotics, cemented/uncemented prostheses and inferior uncemented prostheses (Table III) . The effect of adjustment is shown in Figure 1 , where the best results are seen for patients with primary osteoarthritis among the unadjusted survival curves (Kaplan-Meier curves, left panel), while this disease group is placed in a middle position among the adjusted survival curves (right panel). For congenital dislocation (RR = 1.3, p = 0.03) and the heterogeneous 'other' group (RR = 1.3, p = 0.01) the differences persisted, but were reduced after adjustments ( Fig. 1 and Table III ). The reason for this higher risk for revision in the 'other' group was an increased risk of revision in patients aged 60 years or younger with malignant disease (primary tumour or metastatic disease). The findings for the group of fracture of the femoral neck were an exception since there was no difference between primary osteoarthritis and this group in the unadjusted analysis, but in the adjusted analysis we observed an increased risk for revision (RR = 1.3, p = 0.0005).
Since the policy of using uncemented THR in patients aged under 60 years has been widely adopted in Norway, results are also given separately for patients above or below 60 years of age. The difference in the risk of revision between primary osteoarthritis and the other diseases was small both in the age group under and above 60 years, but there were differences in percentage survival between the age group under and above 60 years. This was best illustrated in the group of primary osteoarthritis since the unadjusted survival percentage for those under 60 years was 78.6% after ten years, and in the age group above 60 years it was 90.1% (Table III) . Follow-up results in the Charnley subgroup. As a supplement to adjustment for cement and type of prosthesis we also studied a large subgroup of Charnley prostheses implanted with high-viscosity cement (Table IV) . With all causes of revision as the endpoint and with adjustment, only prostheses in patients with complications after fracture of the femoral neck had a statistically significant higher risk of revision (RR = 1.5, p = 0.0005) compared with primary osteoarthritis. In the heterogeneous 'other' group we observed an increased risk of revision in patients aged 60 years or younger. This was due to THR in patients with malignant disease.
In the Charnley subgroup the percentage of survival was similar in both age groups (Table IV) , but with a tendency to be less good in the young age group. For the Charnley prostheses with high-viscosity cement in primary osteoarthritis in patients aged under 60 years, survival after ten years was 92.0%, and for those aged over 60 years, 93.5% (Table IV) .
By studying the different causes of failure in the Charnley subgroup we found that, with revision due to dislocation as the endpoint, the prostheses inserted for congenital dislocation had a higher risk of revision of 5.6 times (p = 0.02), and that prostheses inserted because of complications after fracture of the femoral neck had a higher risk of revision of 2.8 times (p < 0.0001) compared with those inserted for primary osteoarthritis (Table V) . With revision for periprosthetic fracture of the femur, the prostheses inserted because of complications of fracture of the femoral neck had a higher risk of revision of 5.0 times (p = 0.002) compared with those for primary osteoarthritis. In the Charnley subgroup we observed more revisions because of aseptic loosening of the femur than for aseptic loosening of the acetabulum in all disease groups (Table V) . 
Discussion
Several diagnoses, found among younger patients, gave a reduced survival compared with primary osteoarthritis, but these patients had often been given inferior uncemented implants, as defined by previous studies. [10] [11] [12] When we applied the Cox model and adjusted for the use of inferior implants, of uncemented and cemented implants, of antibiotic-impregnated cement, and the effect of age and gender, only THR in patients with congenital dislocated hips and in patients after hip fracture had worse results compared with those with primary osteoarthritis. For the group aged over 60 years the percentage of patients with uncemented prostheses and especially inferior uncemented prostheses was small. This gave good survival results for all diagnostic groups, and the differences in risk of revision between primary osteoarthritis and the other hip diseases were low. Since most of the patients with primary osteoarthritis are above 60 years of age, the unadjusted comparison in the overall total gave good results, with relatively worse results for hip diseases in predominantly young patients because of the greater use of inferior uncemented implants in younger patients. Notably, more revisions because of aseptic loosening of the femur than of the acetabulum were found in all disease groups in the Charnley subgroup. This finding is discussed in two recent papers from our register. 8, 18 During the last 20 years the acetabulum of cemented prostheses has been identified as the component which is most likely to fail.
21,22
Harris and Maloney 23 recommended the use of hybrid prostheses with uncemented acetabular and cemented femoral components. Their recommendation was based on the long-term follow-up (15 to 20 years) of Charnley prostheses and follow-up for only five years of uncemented acetabular components. Our results are mid-term (ten years) and so far those for the acetabular components have been better than those for the femoral components. This is consistent with the Mayo clinic experience 24 in which, after follow-up for 20 years, the results were better for the Charnley acetabular components than for the femoral components. Because of the improved polyethylene acetabular design of the Charnley cup, 25 and the third-generation cementing technique with multiple drill holes, high-pressure lavage, vacuum mixing of cement and pressurisation of the cement, the results of cemented cups have improved compared with those in Charnley's first series. 26, 27 The use of the hybrid technique is not supported by our study because of the increasing number of revisions of uncemented acetabular components due to wear and osteolysis after seven to ten years. Uncemented femoral components performed similarly, or slightly better than, cemented femoral components. The results of the different implants are discussed in our latest papers. 8, 18 The general finding in our study is that young patients in all disease groups have good mid-term results using cemented implants. This is in accordance with the study by Wroblewski 32 reported a higher rate of radiologically loose acetabular components in rheumatoid arthritis with the Charnley prosthesis. Two studies using roentgen stereophotogrammetric analysis showed a greater degree of migration of cups in patients with rheumatoid arthritis. 33, 34 This is thought to be due to poor bone stock. One study has also found higher rates of revision because of infection in patients with rheumatoid arthritis. 6 We could not confirm this and our findings were consistent with those of Lehtimäki et al 35 Joshi et al, 3 Sochart and Porter 36 and Önsten, Besjakov and Carlsson.
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Complications of fracture of the femoral neck. For THR in patients with complications after fracture of the femoral neck the unadjusted cumulative survival at ten years, using all causes of revision as the endpoint, was 89.2% compared with 88.8% for patients with primary osteoarthritis. After adjustment, we found an increased risk of revision in the group with complications after fracture of the femoral neck compared with those with primary osteoarthritis. The explanation is that the fracture group consisted of more elderly women in whom cemented prostheses implanted with highviscosity cement with antibiotic were used. This combination of good prognostic factors probably masks the negative effect of the diagnosis. The highest risks for revision were in patients aged 60 years and younger. Our results are consistent with those from the Swedish registry 1 in which a higher rate of revision was found in the group with previous fracture, especially in young men. We found a higher risk of revision because of dislocation in the fracture group compared with those with primary osteoarthritis. This finding has previously been reported in another study from our registry 38 in which all cemented prostheses were analysed. Our results confirm those of Lindberg et al, 39 Hedlundch et al 40 and the Swedish Register, 1 who reported that patients with a previous fracture of the femoral neck had more dislocations than patients with osteoarthritis. Possible explanations may be a greater tendency to fall, less muscular control, an increased incidence of dementia and non co-operative patients, a greater use of sedatives, alcohol abuse, and abnormal local anatomy with limb shortening and scar tissue. There was also an increased risk of revision for periprosthetic fracture of the femur. Congenital dysplasia. In this group there was a high percentage of uncemented and inferior uncemented hip prostheses and, accordingly, the overall unadjusted results were statistically significantly poorer than in primary osteoarthritis. After adjustment these differences disappeared. Our study is in accordance with the findings of Sochart and Porter 36 who found that the Charnley femoral components in dysplastic hips had the best cumulative survival (89%) at 25 years for all diagnoses investigated. Congenital dislocation. There were few patients in this group and conclusions should therefore be drawn with caution. A higher revision risk because of dislocation was found, which seems plausible because of the more difficult local anatomy in these hips. 41 Our results support findings from other studies of the Charnley prosthesis. Numair et al 42 found satisfactory fixation of the femoral component both in subluxed and dislocated congenital dislocated hips after nine years, but the rate of revision of the acetabular component in congenital dislocated hips was twice that in congenital dysplastic hips. Because of the small number of hips in this group we could not find a statistically significant increased risk of revisions due to aseptic loosening of acetabular components, but in a larger study population with a follow-up which was two years shorter, in which Charnley prostheses were cemented with high-viscosity CMW I (De Puy, Leeds, UK), we found higher rates of revision because of aseptic loosening of the acetabular components after congenital dislocation compared with primary osteoarthritis. 43 This is also in accordance with Sochart and Porter 36 who found a high rate of revision of acetabular components in patients with congenital dislocation after follow-up for 25 years. Epiphysiolysis and Perthes' disease. This combined group was small, and we were unable to distinguish between them as they were reported together on the standard form. THR in this group of patients has a good prognosis if a prosthesis with good long-term results is used, with a survival rate of 96.0% at ten years for a Charnley prosthesis with high-viscosity cement. reported an increased risk of revision, but most of the studies described in their review article had not been adjusted for the use of different designs of prosthesis. We had very few patients in this group (0.8% of the overall total). This is different from the USA where 10% of total hip replacements are undertaken in patients who have avascular necrosis. 45 This could be due to differences in the definition of this disease, ethnic differences, or different use of alcohol and corticosteroids in the USA. Although this is a heterogeneous group of patients with different causes of avascular necrosis, in our study they had a good prognosis when prostheses with good long-term results were used. 'Other' hip diseases. In this heterogeneous group we found a higher risk of revision in the unadjusted total material, but this was reduced after adjustments for confounding factors, and the difference was not statistically significant after adjustments in the Charnley subgroup. We found an increased risk of revision both in the overall total and in the Charnley subgroup in patients aged 60 years or younger. This was mainly because of an increased risk of revision in patients with primary malignant or metastatic disease. There were 66 different diseases in this group, which demonstrate the variety of conditions for which total hip replacement may be required. Adjustment of confounding factors. Our findings illustrate the importance of confounding factors such as age, gender, type of implant and fixation in the study of hip replacement. To account for such differences in patient details either multiple-regression analyses, such as the Cox model should be used, or a study made of a homogenous subgroup with the same age, gender, hip disease, implant and fixation method or a combination of these two methods. An illustrative example is the group of patients with fracture of the femoral neck which had the lowest rate of revision in the unadjusted total material, but this group was the only one with a statistically significant higher risk of revision compared with primary osteoarthritis when full adjustment for confounding factors was made in the homogenous Charnley subgroup. Several diagnoses, among younger patients, gave worse results when compared with primary osteoarthritis. After adjustment in a multiple Cox regression model, diagnoses mainly seen among young patients had a good prognosis but these patients had often been given inferior uncemented implants.
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